|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-12-13
|
|
pubmed:abstractText |
Antiglucocorticoids, such as ketoconazole, have been investigated as antidepressant agents in major depression and other conditions. Despite evidence that a significant number of patients with schizophrenia and schizoaffective disorder are both hypercortisolemic and depressed, the antidepressant effects of antiglucocorticoids have never been assessed in these populations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1562-2975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
156-61
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12478881-Adult,
pubmed-meshheading:12478881-Antidepressive Agents,
pubmed-meshheading:12478881-Antipsychotic Agents,
pubmed-meshheading:12478881-Depression,
pubmed-meshheading:12478881-Double-Blind Method,
pubmed-meshheading:12478881-Female,
pubmed-meshheading:12478881-Glucocorticoids,
pubmed-meshheading:12478881-Humans,
pubmed-meshheading:12478881-Hydrocortisone,
pubmed-meshheading:12478881-Ketoconazole,
pubmed-meshheading:12478881-Male,
pubmed-meshheading:12478881-Middle Aged,
pubmed-meshheading:12478881-Pilot Projects,
pubmed-meshheading:12478881-Psychotic Disorders,
pubmed-meshheading:12478881-Questionnaires,
pubmed-meshheading:12478881-Schizophrenia
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study.
|
|
pubmed:affiliation |
University of California, Langley Porter Psychiatric Institute, San Francisco, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
